Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
11
Number of overlapping holdings
17.5%
% of XLV's 64 holdings also in MEDX
36.7%
% of MEDX's 30 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.4% | 15.1% | 11.4% |
|
ABBVIE INC | 5.3% | 7.3% | 5.3% |
|
MERCK & CO. INC. | 6.2% | 5.2% | 5.2% |
|
JOHNSON & JOHNSON | 6.8% | 4.5% | 4.5% |
|
AMGEN INC | 3.1% | 6.1% | 3.1% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to MEDX
|
UNITEDHEALTH GROUP INC | 8.9% |
|
THERMO FISHER SCIENTIFIC INC | 4.3% |
|
ABBOTT LABORATORIES | 3.4% |
|
DANAHER CORP | 3.1% |
|
INTUITIVE SURGICAL INC | 2.6% |
|
ELEVANCE HEALTH INC | 2.4% |
|
JOHNSON & JOHNSON | 2.3% |
|
STRYKER CORP | 2.1% |
 |
MEDTRONIC PLC | 2.1% |
|
VERTEX PHARMACEUTICALS INC | 2.0% |
XLV Underweight Relative to MEDX
 |
NOVARTIS AG-ADR | -5.8% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.7% |
|
ELI LILLY & CO | -3.7% |
|
BIOGEN IDEC INC | -3.5% |
|
ALKERMES PLC | -3.3% |
|
CRISPR THERAPEUTICS AG | -3.2% |
|
AMGEN INC | -3.0% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -3.0% |
|
BRISTOL-MYERS SQUIBB CO | -3.0% |
|
IONIS PHARMACEUTICALS, INC. | -2.9% |